Literature DB >> 15365711

Predictors of response in a sample of treatment-resistant psychotic patients on clozapine.

Antonio Ciapparelli1, Francesca Ducci, Claudia Carmassi, Marina Carlini, Rosemma Paggini, Mario Catena, Matteo Bottai, Liliana Dell'Osso.   

Abstract

This study aims at identifying potential predictors of clinical response and functional outcome in 101 neuroleptic-refractory patients with a DSM-III-R diagnosis of schizophrenia (N = 34), schizoaffective disorder (N = 30) or bipolar disorder with psychotic features (N = 37), naturalistically treated with clozapine over a 48-month period. The "clinical response" and "functional outcome" criteria were respectively defined a priori as: a reduction of at least 50 % in the Brief Psychiatric Rating Scale total score in one evaluation with respect to baseline; and a Global Assessment of Functioning Scale score of at least 50. Several clinical and socio-demographic variables were assessed at baseline and only the diagnosis of bipolar disorder was significantly related with the clinical response. Variables significantly related with the functional outcome were female gender, university education and early age at onset.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365711     DOI: 10.1007/s00406-004-0511-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  30 in total

Review 1.  Who should receive clozapine?

Authors:  S R Marder; T Van Putten
Journal:  Arch Gen Psychiatry       Date:  1988-09

Review 2.  Neuroleptics and the natural course of schizophrenia.

Authors:  R J Wyatt
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

3.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

4.  Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

Authors:  Daniel S Umbricht; William C Wirshing; Donna A Wirshing; Marjorie McMeniman; Nina R Schooler; Stephen R Marder; John M Kane
Journal:  J Clin Psychiatry       Date:  2002-05       Impact factor: 4.384

5.  Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

Authors:  Antonio Ciapparelli; Liliana Dell'Osso; Adolfo Bandettini di Poggio; Claudia Carmassi; Donatella Cecconi; Melania Fenzi; Maria C Chiavacci; Matteo Bottai; Carla E Ramacciotti; Giovanni B Cassano
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

6.  Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

Authors:  D Pickar; R R Owen; R E Litman; E Konicki; R Gutierrez; M H Rapaport
Journal:  Arch Gen Psychiatry       Date:  1992-05

7.  Clozapine for treatment-refractory mania.

Authors:  J R Calabrese; S E Kimmel; M J Woyshville; D J Rapport; C J Faust; P A Thompson; H Y Meltzer
Journal:  Am J Psychiatry       Date:  1996-06       Impact factor: 18.112

8.  Gender and the course of schizophrenia: differences in treated outcomes.

Authors:  M C Angermeyer; L Kühn; J M Goldstein
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

9.  Is clozapine a mood stabilizer?

Authors:  C A Zarate; M Tohen; M D Banov; M K Weiss; J O Cole
Journal:  J Clin Psychiatry       Date:  1995-03       Impact factor: 4.384

10.  Current outcome in schizophrenia: women vs men.

Authors:  M V Seeman
Journal:  Acta Psychiatr Scand       Date:  1986-06       Impact factor: 6.392

View more
  5 in total

1.  Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors:  Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-19       Impact factor: 5.270

Review 2.  Clinical Predictors of Response to Clozapine in Patients with Treatment Resistant Schizophrenia.

Authors:  Rajkumar A P; Chitra C; Bhuvaneshwari S; Poonkuzhali B; Kuruvilla A; Jacob K S
Journal:  Psychopharmacol Bull       Date:  2011-09-15

Review 3.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

Review 4.  A Role for Oxytocin in the Etiology and Treatment of Schizophrenia.

Authors:  Megan Elizabeth Rich; Heather Kingsley Caldwell
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-03       Impact factor: 5.555

5.  Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital.

Authors:  Wenying Yi; Shenglin She; Jie Zhang; Haibo Wu; Yingjun Zheng; Yuping Ning
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-24       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.